36
https://pubmed.ncbi.nlm.nih.gov/38112106
Azvudine and nirmatrelvir-ritonavir were found to improve the prognosis of hospitalized adults with moderate-to-severe COVID-19.
“Azvudine and Nirmatrelvir-Ritonavir Improve Prognosis of Hospitalized Adults with Moderate-to-Severe COVID-19: A Study”
